Sfoglia per Rivista
The mevalonate pathway as a metabolic target to circumvent multidrug-resistance in chronic lymphocytic leukemia cells (CLL)
2012-01-01 Micol Rigoni; Marta Coscia; Chiara Riganti; Ivana Campia; Silvia Peola; Barbara Castella; Valentina Griggio; Francesca Pantaleoni; Patrizia Sciancalepore; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia
The PAX5 gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome. A report on behalf of the GIMEMA Acute Leukemia Working Party
2010-01-01 Iacobucci I; Lonetti A; Paoloni F; Papayannidis C; Ferrari A; Storlazzi CT; Vignetti M; Cilloni D; Messa F; Guadagnuolo V; Paolini S; Elia L; Messina M; Vitale A; Meloni G; Soverini S; Pane F; Baccarani M; Foà R; Martinelli G.
The prognostic value of bone involvement in childhood acute lymphoblastic leukaemia (author's transl)
1981-01-01 Pastore G; Miniero R; Cordero di Montezemolo L; Felicioni V; Fiandino G; Grazia G; Morgando MP; Trada M; Madon E.
The response to imatinib and interferon-alpha is more rapid than the response to imatinib alone: a retrospective analysis of 495 Philadelphia-positive chronic myeloid leukemia patients in early chronic phase
2010-01-01 Palandri F; Castagnetti F; Iacobucci I; Martinelli G; Amabile M; Gugliotta G; Poerio A; Testoni N; Breccia M; Bocchia M; Crugnola M; Rege-Cambrin G; Martino B; Pierri I; Radaelli F; Specchia G; Pane F; Saglio G; Rosti G; Baccarani M.
The role of BCR/ABL isoforms in the presentation and outcome of patients withPhiladelphia-positive acute lymphoblastic leukemia: a seven-year update of theGIMEMA 0496 trial.
2006-01-01 Cimino G; Pane F; Elia L; Finolezzi E; Fazi P; Annino L; Meloni G; Mancini M; Tedeschi A; Di Raimondo F; Specchia G; Fioritoni G; Leoni P; Cuneo A; Mecucci C; Saglio G; Mandelli F; Foà R; GIMEMA Leukemia Working Party
THE SURVIVAL OF TUMOR CELLS IN IGVH UNMUTATED CHRONIC LYMPHOCYTIC LEUKEMIA IS HIGHLY DEPENDENT ON EXOGENOUS SIGNALS DELIVERED BY THE TUMOR MICROENVIRONMENT
2009-01-01 Coscia M; Pantaleoni F; Riganti C; Rigoni M; Vitale C; Peola S; Drandi D; Ladetto M; Bosia A; Boccadoro M; Massaia M.
The unbalanced ratio between KTS- and KTS+ isoforms of WT1 may probably be responsible for the dysfunction of its physiological role in leukemic cells
2005-01-01 Defilippi I; Messa F; Arruga F; Serra A; Rosso V; Catalano R; Reviglione R; Morotti A; Messa E; Carturan S; Gottardi E; Bracco E; Saglio G; Cilloni D
The use of differentiated regimens in therapy of children with acute lymphoblastic leukemia
1983-01-01 Madon E; Pastore G; Cordero Di Montezemolo L; Grazia G; Brach Del Prever A.
Thrombophilia in thalassemia major patients: analysis of genetic predisposing factors
2001-01-01 IOLASCON A;GIORDANO P;STORELLI S;LI HH;COPPOLA B;PIGA A;FANTOLA E;FORNI G;CIANCIULLI P;PERROTTA S;MAGNANO C;MAGGIO A;MANGIAGLI A;DEVOTO M
Thrombophilic mutations are a main risk factor for placental abruption.
2003-01-01 Facchinetti F; Marozio L; Grandone E; Pizzi C; Volpe A; Benedetto C.
THROMBOPROPHYLAXIS FOR NEWLY DIAGNOSED MULTIPLEMYELOMA PATIENTS TREATED WITH LENALIDOMIDE-BASEDREGIMENS: A RANDOMIZED PHASE III STUDY OF ASPIRINVS ENOXAPARIN
2011-01-01 A Larocca; F Cavallo; A Evangelista; F Di Raimondo; L Catalano; M Galli; C Cangialosi; G Benevolo; D Rossi; T Guglielmelli; L Masini;F Rossi; R Ria; N Cascavilla; N Pescosta;A Baraldi; M Marcatti; T Caravita Di Toritto;A Nagler;M Boccadoro; A Palumbo
THYMIC OUTPUT AND T CELL RECONSTITUTION FOLLOWING NON-MYELOABLATIVE ALLOGRAFTING
2008-01-01 Bruno B; Sfiligoi C; Omedè P; Cena S; Spagnolo M; Testa C; Cimolin L; Resta I; Sorasio R; Resta I; Giaccone L; Boccadoro M
Total body irradiation: Recent radiobiological and technological acquisitions [Irradiazione corporea totale: Recenti acquisizioni radiobiologiche e tecnologiche]
2008-01-01 Corvò; R.; Barra; S.; Filippi; A.; Ricardi; U.
Transferrin receptor 2 and HFE regulate furin expression via mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/Erk) signaling. Implications for transferrin-dependent hepcidin regulation
2010-01-01 M. Poli;S. Luscieti;V. Gandini;F. Maccarinelli;D. Finazzi;L. Silvestri;A. Roetto;P. Arosio
Trisomy 11 in myeloid malignancies is associated with internal tandem duplication of both MLL and FLT3 genes
2005-01-01 REGE-CAMBRIN, G; Giugliano, E; Michaux, L; Stul, M; Scaravaglio, P; Serra, A; Saglio, G; Hagemeijer, A.
The tryptophan metabolism in the immune dysregulation of multiple myeloma
2007-01-01 Fiore F, Castella B, Assalto C, Zappia S, Hwang SY, Vitale C, Boccadoro M, Massaia M
TWO DOSE-INTENIVE MELPHALAN REGIMENS (100 MG/M2 VERSUS 200 MG/M2) IN MULTIPLE MYELOMA PATIENTS
2003-01-01 Bringhen S; Bertola A; Cavallo F; Falco P; Massaia M; Bruno B; Barbui A; Caravita T; Musto P; Pescosta N; Rossini F; Vignetti M; Boccadoro M; Palumbo A
Two new translocations involving the 11q23 region map outside the MLL locus in myeloid leukemias
2002-01-01 GIUGLIANO E; REGE-CAMBRIN G; SCARAVAGLIO P; WLODARSKA I; EMANUEL B; STUL M; SERRA A; TONSO A; PINI M; G. SAGLIO; HAGEMEIJER A
TYROSINE KINASE INHIBITORS DISCONTINUATION IN CHRONIC MYELOID LEUKEMIA: A RETROSPECTIVE ANALYSIS OF 208 ITALIAN PATIENTS
2016-01-01 Fava, C; Rege-Cambrin, G; Dogliotti, I; Berchialla, P; Abruzzese, E; Annunziata, M; Avanzini, P; Bergamaschi, M; Bocchia, M; Caocci, G; Catania, G; Cattaneo, D; Cavazzini, F; Cerrano, M; Chiara, E; Crugnola, M; Galimberti, S; Gambacorti-Passerini, C; Iuliano, F; Iurlo, A; Levato, L; Luciano, L; Musto, P; Orlandi, E; Pregno, P; Rapezzi, D; Russo, S; Santoro, M; Sora, F; Baccarani, M; Ferrero, D; Saglio, G.
TYROSINE KINASE INHIBITORS SIGNIFICANTLY CHANGE THE EXPRESSION OF POLYCOMB GENES IN CHRONIC MYELOID LEUKEMIA
2017-01-01 Grassi S, Palumbo S, Arrigoni E, Ciabatti E, Mariotti V, Ercolano G, Guerrini F, Di Vita A, Pacini S, Montali M, Barachini S, Domenichini C, Tarrini G, Salehzadeh S, Vangeli M, Metelli MR, Pellegrini S, Ricci F, Perutelli F, Baratè C, Petrini M, Di Paolo A, Galimberti S.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| The mevalonate pathway as a metabolic target to circumvent multidrug-resistance in chronic lymphocytic leukemia cells (CLL) | 2012 | Micol Rigoni; Marta Coscia; Chiara Riganti; Ivana Campia; Silvia Peola; Barbara Castella; Valentina Griggio; Francesca Pantaleoni; Patrizia Sciancalepore; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia | |
| The PAX5 gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome. A report on behalf of the GIMEMA Acute Leukemia Working Party | 2010 | Iacobucci I; Lonetti A; Paoloni F; Papayannidis C; Ferrari A; Storlazzi CT; Vignetti M; Cilloni D; Messa F; Guadagnuolo V; Paolini S; Elia L; Messina M; Vitale A; Meloni G; Soverini S; Pane F; Baccarani M; Foà R; Martinelli G. | |
| The prognostic value of bone involvement in childhood acute lymphoblastic leukaemia (author's transl) | 1981 | Pastore G; Miniero R; Cordero di Montezemolo L; Felicioni V; Fiandino G; Grazia G; Morgando MP; Trada M; Madon E. | |
| The response to imatinib and interferon-alpha is more rapid than the response to imatinib alone: a retrospective analysis of 495 Philadelphia-positive chronic myeloid leukemia patients in early chronic phase | 2010 | Palandri F; Castagnetti F; Iacobucci I; Martinelli G; Amabile M; Gugliotta G; Poerio A; Testoni N; Breccia M; Bocchia M; Crugnola M; Rege-Cambrin G; Martino B; Pierri I; Radaelli F; Specchia G; Pane F; Saglio G; Rosti G; Baccarani M. | |
| The role of BCR/ABL isoforms in the presentation and outcome of patients withPhiladelphia-positive acute lymphoblastic leukemia: a seven-year update of theGIMEMA 0496 trial. | 2006 | Cimino G; Pane F; Elia L; Finolezzi E; Fazi P; Annino L; Meloni G; Mancini M; Tedeschi A; Di Raimondo F; Specchia G; Fioritoni G; Leoni P; Cuneo A; Mecucci C; Saglio G; Mandelli F; Foà R; GIMEMA Leukemia Working Party | |
| THE SURVIVAL OF TUMOR CELLS IN IGVH UNMUTATED CHRONIC LYMPHOCYTIC LEUKEMIA IS HIGHLY DEPENDENT ON EXOGENOUS SIGNALS DELIVERED BY THE TUMOR MICROENVIRONMENT | 2009 | Coscia M; Pantaleoni F; Riganti C; Rigoni M; Vitale C; Peola S; Drandi D; Ladetto M; Bosia A; Boccadoro M; Massaia M. | |
| The unbalanced ratio between KTS- and KTS+ isoforms of WT1 may probably be responsible for the dysfunction of its physiological role in leukemic cells | 2005 | Defilippi I; Messa F; Arruga F; Serra A; Rosso V; Catalano R; Reviglione R; Morotti A; Messa E; Carturan S; Gottardi E; Bracco E; Saglio G; Cilloni D | |
| The use of differentiated regimens in therapy of children with acute lymphoblastic leukemia | 1983 | Madon E; Pastore G; Cordero Di Montezemolo L; Grazia G; Brach Del Prever A. | |
| Thrombophilia in thalassemia major patients: analysis of genetic predisposing factors | 2001 | IOLASCON A;GIORDANO P;STORELLI S;LI HH;COPPOLA B;PIGA A;FANTOLA E;FORNI G;CIANCIULLI P;PERROTTA S;MAGNANO C;MAGGIO A;MANGIAGLI A;DEVOTO M | |
| Thrombophilic mutations are a main risk factor for placental abruption. | 2003 | Facchinetti F; Marozio L; Grandone E; Pizzi C; Volpe A; Benedetto C. | |
| THROMBOPROPHYLAXIS FOR NEWLY DIAGNOSED MULTIPLEMYELOMA PATIENTS TREATED WITH LENALIDOMIDE-BASEDREGIMENS: A RANDOMIZED PHASE III STUDY OF ASPIRINVS ENOXAPARIN | 2011 | A Larocca; F Cavallo; A Evangelista; F Di Raimondo; L Catalano; M Galli; C Cangialosi; G Benevolo; D Rossi; T Guglielmelli; L Masini;F Rossi; R Ria; N Cascavilla; N Pescosta;A Baraldi; M Marcatti; T Caravita Di Toritto;A Nagler;M Boccadoro; A Palumbo | |
| THYMIC OUTPUT AND T CELL RECONSTITUTION FOLLOWING NON-MYELOABLATIVE ALLOGRAFTING | 2008 | Bruno B; Sfiligoi C; Omedè P; Cena S; Spagnolo M; Testa C; Cimolin L; Resta I; Sorasio R; Resta I; Giaccone L; Boccadoro M | |
| Total body irradiation: Recent radiobiological and technological acquisitions [Irradiazione corporea totale: Recenti acquisizioni radiobiologiche e tecnologiche] | 2008 | Corvò; R.; Barra; S.; Filippi; A.; Ricardi; U. | |
| Transferrin receptor 2 and HFE regulate furin expression via mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/Erk) signaling. Implications for transferrin-dependent hepcidin regulation | 2010 | M. Poli;S. Luscieti;V. Gandini;F. Maccarinelli;D. Finazzi;L. Silvestri;A. Roetto;P. Arosio | |
| Trisomy 11 in myeloid malignancies is associated with internal tandem duplication of both MLL and FLT3 genes | 2005 | REGE-CAMBRIN, G; Giugliano, E; Michaux, L; Stul, M; Scaravaglio, P; Serra, A; Saglio, G; Hagemeijer, A. | |
| The tryptophan metabolism in the immune dysregulation of multiple myeloma | 2007 | Fiore F, Castella B, Assalto C, Zappia S, Hwang SY, Vitale C, Boccadoro M, Massaia M | |
| TWO DOSE-INTENIVE MELPHALAN REGIMENS (100 MG/M2 VERSUS 200 MG/M2) IN MULTIPLE MYELOMA PATIENTS | 2003 | Bringhen S; Bertola A; Cavallo F; Falco P; Massaia M; Bruno B; Barbui A; Caravita T; Musto P; Pescosta N; Rossini F; Vignetti M; Boccadoro M; Palumbo A | |
| Two new translocations involving the 11q23 region map outside the MLL locus in myeloid leukemias | 2002 | GIUGLIANO E; REGE-CAMBRIN G; SCARAVAGLIO P; WLODARSKA I; EMANUEL B; STUL M; SERRA A; TONSO A; PINI M; G. SAGLIO; HAGEMEIJER A | |
| TYROSINE KINASE INHIBITORS DISCONTINUATION IN CHRONIC MYELOID LEUKEMIA: A RETROSPECTIVE ANALYSIS OF 208 ITALIAN PATIENTS | 2016 | Fava, C; Rege-Cambrin, G; Dogliotti, I; Berchialla, P; Abruzzese, E; Annunziata, M; Avanzini, P; Bergamaschi, M; Bocchia, M; Caocci, G; Catania, G; Cattaneo, D; Cavazzini, F; Cerrano, M; Chiara, E; Crugnola, M; Galimberti, S; Gambacorti-Passerini, C; Iuliano, F; Iurlo, A; Levato, L; Luciano, L; Musto, P; Orlandi, E; Pregno, P; Rapezzi, D; Russo, S; Santoro, M; Sora, F; Baccarani, M; Ferrero, D; Saglio, G. | |
| TYROSINE KINASE INHIBITORS SIGNIFICANTLY CHANGE THE EXPRESSION OF POLYCOMB GENES IN CHRONIC MYELOID LEUKEMIA | 2017 | Grassi S, Palumbo S, Arrigoni E, Ciabatti E, Mariotti V, Ercolano G, Guerrini F, Di Vita A, Pacini S, Montali M, Barachini S, Domenichini C, Tarrini G, Salehzadeh S, Vangeli M, Metelli MR, Pellegrini S, Ricci F, Perutelli F, Baratè C, Petrini M, Di Paolo A, Galimberti S. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile